28%
less contrast agent [2]
The DCR4 Contrast trial demonstrated that DCR guidance reduces the amount of contrast used during PCI compared to angiographic guidance. DCR lowered the number of cineangiography runs, highlighting its potential as a contrast-sparing tool for PCI, benefiting patients at risk of CI-AKI.
25%
reduction of time overages for planned cases [2]
The DCR4 Contrast trial demonstrated that DCR guidance reduces time for planned PCI cases by significantly lowering the number of cineangiography runs compared to angiographic guidance. This suggests that DCR can enhance efficiency while minimizing contrast use, benefiting both workflow and safety.
76%
more staff confidence making treatment decisions [3]
A survey of 38 participants across six countries found that the Philips Coronary Suite increased confidence in making treatment decisions compared to multi-vendor cath labs. Clinicians with experience in both settings reported enhanced decision-making support.
Improve speed of adoption
Philips builds simplicity into its products, so that you can trust our easy-to-use advanced technology, and focus on what matters most, your patients.
Ease procedural complexity
Philips provides you with the most complete set of interventional tools to thoroughly assess lesions, plan treatments and improve patient outcomes.
Streamline cath lab workflows
The cath lab can be the least standardized area in a hospital. Philips offers a comprehensive suite of solutions to standardize workflows.